Atlas FDA

OptiVantage DH Power Injection System.

FDA device recall Z-0288-2007 · posted 2006-12-16 · Terminated

Recall details

Recalling firm
Mallinckrodt Inc
Reason for recall
The flow rate programmed on the console may be changed without automatically updating the flow rate programmed on the power head. The injector will always inject in accordance with the parameters shown on the power head. If this lack of synchronization occurs and is not noticed by the clinican, contrast would be injected at a higher or lower flow rate than desired.
Action taken
The recalling firm sent a letter dated 11/7/2006 to all consignees.
Root cause
Other
Status
Terminated
Product code
CXT
Quantity affected
1348 devices.
Distribution
Worldwide distribution ---- including USA and countries of Australia, Belgium, Brazil, Canada, Chile, Columbia, Denmark, Mexico, Panama, Puerto Rico, Singapore and South Africa.
Date initiated
2006-11-07
Date posted
2006-12-16
Date terminated
2007-07-21
Location
Cincinnati, OH

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
OPTIV ANTAGE DH POWER INJECTION SYSTEM (K042744)Mallinckrodt Inc., Liebel-Flarsheim Business2004-11-30